Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
36.16
-0.75 (-2.03%)
Dec 31, 2024, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SUPN stock has a target of 36, which predicts a decrease of -0.44% from the current stock price of 36.16.
Analyst Consensus: Hold
* Price targets were last updated on Sep 11, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for SUPN is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $41 → $36 | Buy → Hold | Downgrades | $41 → $36 | -0.44% | Sep 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +13.38% | Feb 28, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $43 | Buy | Maintains | $42 → $43 | +18.92% | Nov 9, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $42 | Buy | Maintains | $43 → $42 | +16.15% | Oct 25, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $46 | Buy | Maintains | $45 → $46 | +27.21% | May 10, 2023 |
Financial Forecast
Revenue This Year
655.00M
from 607.52M
Increased by 7.82%
Revenue Next Year
633.26M
from 655.00M
Decreased by -3.32%
EPS This Year
2.91
from 0.02
Increased by 14,469.02%
EPS Next Year
1.93
from 2.91
Decreased by -33.72%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 678.8M | 673.6M | 738.8M | |||
| Avg | 655.0M | 633.3M | 689.5M | |||
| Low | 627.2M | 600.4M | 620.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 11.7% | 2.8% | 16.7% | |||
| Avg | 7.8% | -3.3% | 8.9% | |||
| Low | 3.2% | -8.3% | -2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.05 | 2.15 | 2.86 | |||
| Avg | 2.91 | 1.93 | 2.38 | |||
| Low | 2.77 | 1.70 | 1.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 15,125.0% | -26.1% | 47.9% | |||
| Avg | 14,469.0% | -33.7% | 23.2% | |||
| Low | 13,767.0% | -41.8% | -2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.